Startup mines consumer data to offer drug-taking info and advice

| | Health Exec | Economics

Iodine, a new company slated to launch next week, will harness Google Consumer Surveys to provide an online service with tailored drug-taking information and advice, reports The New York Times.

With 100,000 surveys completed and more added daily, Iodine is building the largest survey ever taken of Americans’ drug experience, intended to help consumers and perhaps guide policy, according to its founders Thomas Goetz, formerly of Wired magazine, and Google engineer Matt Mohebbi.

Read more about this venture below:

 

To Gather Drug Data, a Health Start-Up Turns to Consumers

Related Content

Merck spends up to $2B to license new weight loss drug with potential heart benefits
Insulet wins $452M in lawsuit against rivals over medical device trade secrets
Medical device company cuts 70% of staff in push to meet Medtronic obligations
Cleerly’s momentum continues as AI specialists raise $106M
Operations manager, doctors charged in $70M imaging kickback scheme
Private-equity watchdog warns against nominating Marc Rowan as Treasury Secretary

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.